| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 651.47M | 753.55M | 812.92M | 964.25M | 756.12M |
| Gross Profit | 56.15M | 96.63M | 130.09M | 48.06M | 11.59M |
| EBITDA | -63.46M | 2.97M | 113.44M | 61.91M | -82.84M |
| Net Income | -204.50M | -103.88M | 51.17M | -28.97M | -159.70M |
Balance Sheet | |||||
| Total Assets | 698.73M | 911.02M | 1.06B | 1.09B | 1.17B |
| Cash, Cash Equivalents and Short-Term Investments | 153.85M | 163.86M | 198.11M | 190.65M | 267.43M |
| Total Debt | 183.67M | 148.50M | 218.15M | 219.61M | 259.51M |
| Total Liabilities | 489.40M | 513.77M | 553.49M | 620.87M | 668.32M |
| Stockholders Equity | 88.51M | 273.65M | 382.92M | 351.74M | 384.64M |
Cash Flow | |||||
| Free Cash Flow | -35.63M | 17.23M | 23.16M | -37.57M | -69.82M |
| Operating Cash Flow | -21.19M | 74.02M | 51.22M | -23.35M | -35.52M |
| Investing Cash Flow | 14.60M | -9.29M | -22.55M | 2.30M | -194.74M |
| Financing Cash Flow | -7.16M | -93.63M | -13.92M | -50.04M | 160.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$47.30B | 11.05 | 9.96% | 6.39% | -8.51% | 9.94% | |
75 Outperform | HK$91.35B | ― | 7.60% | ― | 18.89% | 6.97% | |
65 Neutral | HK$11.51B | 4.20 | 8.00% | 3.55% | -3.33% | -8.42% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | HK$985.60M | ― | 4.09% | 0.60% | 9.53% | -51.48% | |
53 Neutral | HK$1.08B | 118.84 | 0.70% | ― | -33.06% | -92.21% | |
40 Underperform | HK$173.04M | -0.24 | -35.39% | ― | -13.55% | -96.99% |